author-photo

Ward Posthuma

Leiden University Medical Center

14

Papers

15

Citations

Citation Trend

Filter By

Papers (10) Sort By

Journal Conference Others

Integration of Mutational Signature Analysis with 3D Chromatin Data Unveils Differential AID-Related Mutagenesis in Indolent Lymphomas

2021 International Journal of Molecular Sciences
Show All
- Source
- Cite
- Save
Citations (0)
Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy; results from the HOVON 109 study

2020 Experimental Hematology
Show All
- Source
- Cite
- Save
Citations (2)
High Frequencies of Mutated EZH2 and IRF8 and Other Epigenetic Genes in Primary Bone Lymphomas Are Indicative of GCB-Phenotype

2019 Blood
Show All
- Source
- Cite
- Save
Citations (0)
MOLECULAR PROFILING OF PRIMARY BONE LYMPHOMAʼS REVEALS FREQUENT MUTATIONS IN EZH2 AND OTHER EPIGENETIC GENES: IMPLICATIONS FOR TARGETED TREATMENT: PF519

2019
Show All
- Source
- Cite
- Save
Citations (0)
Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia

2019 Haematologica
Show All
- Source
- Cite
- Save
Citations (8)
Efficacy and Safety of First-Line Therapy with Chlorambucil, Rituximab and Individualized Dose Lenalidomide in FCR-Unfit Patients with Advanced Chronic Lymphocytic Leukemia (CLL): A Phase I/II HOVON Trial

2017 Blood
Show All
- Source
- Cite
- Save
Citations (0)
High Prevalence of Oncogenic MYD88 and CD79B Mutations in Intravascular Large B-Cell Lymphoma: Implication for Therapy with Bruton's Kinase Inhibitors?

2017 Blood
Show All
- Source
- Cite
- Save
Citations (1)
HOVON 109: de effectiviteit en veiligheid van eerstelijnsbehandeling van chronische lymfatische leukemie met chloorambucil, rituximab en lenalidomide bij oudere patienten en patienten met comorbiditeit; een fase I/II-studie

2012
Show All
- Source
- Cite
- Save
Citations (0)
Adoptive Immunotherapy with Donor Lymphocyte Infusions after T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients with Acute Myeloid Leukemia.

2005 Blood
Show All
- Source
- Cite
- Save
Citations (1)
A Two Step Nonmyeloablative Allogeneic Transplantation Protocol Using In Vitro T-Cell Depleted Mobilized Stem Cells Followed by Donor Lymphocyte Infusions in Patients with Advanced CLL.

2005 Blood
Show All
- Source
- Cite
- Save
Citations (0)